Hebenrun for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a treatment called Hebenrun to see if it helps control blood sugar in people with type 2 diabetes. It aims to confirm whether it is safe and effective for managing the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have type 2 diabetes with an HbA1c (average blood sugar) between 6.5% and 8.5%.
- You are not pregnant or planning to become pregnant during the study.
- You do not have severe heart, liver, or kidney disease, or other serious health conditions.
- You are willing to follow the study plan and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
This study tests whether a new tablet called HRS9531 helps people with type 2 diabetes control their blood sugar better. You would take it along with your current diabetes management (lifestyle changes or metformin) over several months.
This trial tests a combination of three diabetes medicines (henagliflozin, retagliptin, and extended-release metformin) to see if they are safe and effective for Chinese adults with type 2 diabetes. You may join if you are newly diagnosed or have been taking one oral diabetes pill but need better blood sugar control.
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
Hear when a new Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.